Skip to main content
Clinical Trials/ACTRN12620001090909
ACTRN12620001090909
Not yet recruiting
未知

Pilot evaluation of a digital platform to support self-management of cardiovascular disease

Deakin University0 sites30 target enrollmentOctober 20, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Cardiovascular Disease
Sponsor
Deakin University
Enrollment
30
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 20, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Eligible participants will have a documented clinical diagnosis of cardiovascular disease, be community dwelling outpatients (clinically stable), have access to internet (web\-based access via computer, tablet or smartphone) and be able to read and understand English.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Development and evaluation of an online platform for advanced cancer patients who obtain durable response to immunotherapy or targeted therapy in co-creation with patients, psychologists and service providers.distress symptomsPsychological distress10001302
NL-OMON56652niversiteit van Tilburg57
Completed
Not Applicable
The development and pilot evaluation of an online mental health education program for physician supervisorsSupervisor physicians' behaviour towards mental health issues among traineesSupervisor physicians' confidence in supporting trainees experiencing mental health issuesSupervisor physicians' confidence in supporting mental health needs of all traineesMental Health - DepressionMental Health - AnxietyMental Health - Other mental health disorders
ACTRN12619000858190Black Dog Institute30
Completed
Not Applicable
Development and a pilot trial of an internet-based educational program for reducing heavy drinkingAlcohol use disorder
JPRN-UMIN000030395Graduate School of Education, the University of Tokyo600
Active, not recruiting
Phase 1
A phase I/II open-label platform study to evaluate the safety and efficacy of multiple amivantamab-based therapeutic combinations in participants with advanced, unresectable lung cancernresectable metastatic non-small cell lung cancerCancer
ISRCTN23584582Janssen-Cilag International NV201
Completed
Not Applicable
Effectiveness of Digital therapeutics in clinical symptoms of Attention Deficit/Hyperactivity DisorderMental and behavioural disorders
KCT0007579CHUNGNAM NATIONAL UNIVERSITY SEJONG HOSPITA40